Glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R), two clinically validated drug targets in patients with type 2 diabetes, were used as an example for functional divergence analysis. The gene discussed is GCGR; the disease is type 2 diabetes mellitus.